Skip to main content
ZVRA logo

ZVRA

Zevra Therapeutics, Inc.
$12.77 +0.01 (+0.08%) At close · Jul 17
Market Cap
$754.90M
Shares
59,115,084

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
LaDuane Clifton $3,821,924
Neil F. McFarlane $3,782,042
Rahsaan W. Thompson $1,571,374
Fiscal 2024
Executive Total
Neil F. McFarlane $5,355,059
LaDuane Clifton $1,450,273
Fiscal 2023
Executive Total
Richard Pascoe $4,122,558
Travis Mickle $3,593,438
Neil F. McFarlane $3,445,231
LaDuane Clifton $2,263,257
Joshua M. Schafer $1,814,465
Christal Mickle $1,669,956
Fiscal 2022
Executive Total
Travis Mickle $2,400,356
Richard Pascoe $1,360,976
LaDuane Clifton $1,038,007
Fiscal 2021
Executive Total
Travis Mickle $2,657,059
Sven Guenther $1,082,153
LaDuane Clifton $1,056,212
Richard Pascoe $712,482
Fiscal 2020
Executive Total
Travis Mickle $967,979
Sven Guenther $563,331
LaDuane Clifton $541,114
Fiscal 2019
Executive Total
Travis Mickle $1,360,174
Sven Guenther $687,731
LaDuane Clifton $664,487
Fiscal 2018
Executive Total
Travis Mickle $1,423,379
Sven Guenther $693,606
LaDuane Clifton $647,324
Key facts CIK 1434647 CUSIP 488445206 13F (30d) 11 filings 11 filers Visit website Investor relations